<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">28407774</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>07</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-4598</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Apr</Month>
              <Day>13</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular cancer</Title>
          <ISOAbbreviation>Mol Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway.</ArticleTitle>
        <Pagination>
          <StartPage>79</StartPage>
          <MedlinePgn>79</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">79</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12943-017-0648-1</ELocationID>
        <Abstract>
          <AbstractText>Cancer cells are frequently confronted with metabolic stress in tumor microenvironments due to their rapid growth and limited nutrient supply. Metabolic stress induces cell death through ROS-induced apoptosis. However, cancer cells can adapt to it by altering the metabolic pathways. AMPK and AKT are two primary effectors in response to metabolic stress: AMPK acts as an energy-sensing factor which rewires metabolism and maintains redox balance. AKT broadly promotes energy production in the nutrient abundance milieu, but the role of AKT under metabolic stress is in dispute. Recent studies show that AMPK and AKT display antagonistic roles under metabolic stress. Metabolic stress-induced ROS signaling lies in the hub between metabolic reprogramming and redox homeostasis. Here, we highlight the cross-talk between AMPK and AKT and their regulation on ROS production and elimination, which summarizes the mechanism of cancer cell adaptability under ROS stress and suggests potential options for cancer therapeutics.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Xingbin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yajing</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dong</LastName>
            <ForeName>Shumin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wen</LastName>
            <ForeName>Zhaowei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Wanming</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Shuyi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Qiong</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shi</LastName>
            <ForeName>Min</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. nfyyshimin@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>04</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Mol Cancer</MedlineTA>
        <NlmUniqueID>101147698</NlmUniqueID>
        <ISSNLinking>1476-4598</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.31</RegistryNumber>
          <NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013312" MajorTopicYN="Y">Stress, Physiological</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">AKT</Keyword>
        <Keyword MajorTopicYN="Y">AMPK</Keyword>
        <Keyword MajorTopicYN="Y">FOXO</Keyword>
        <Keyword MajorTopicYN="Y">Metabolic stress</Keyword>
        <Keyword MajorTopicYN="Y">Reactive oxygen species</Keyword>
        <Keyword MajorTopicYN="Y">mTOR</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>1</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>4</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>7</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28407774</ArticleId>
        <ArticleId IdType="pmc">PMC5390360</ArticleId>
        <ArticleId IdType="doi">10.1186/s12943-017-0648-1</ArticleId>
        <ArticleId IdType="pii">10.1186/s12943-017-0648-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Jin S, White E. Role of autophagy in cancer: management of metabolic stress. Autophagy. 2007;3:28–31. doi: 10.4161/auto.3269.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/auto.3269</ArticleId>
            <ArticleId IdType="pmc">PMC2770734</ArticleId>
            <ArticleId IdType="pubmed">16969128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gimbrone MA, Leapman SB, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med. 1972;136:261–76. doi: 10.1084/jem.136.2.261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.136.2.261</ArticleId>
            <ArticleId IdType="pmc">PMC2139203</ArticleId>
            <ArticleId IdType="pubmed">5043412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 2011;91:1071–121. doi: 10.1152/physrev.00038.2010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00038.2010</ArticleId>
            <ArticleId IdType="pmc">PMC3258432</ArticleId>
            <ArticleId IdType="pubmed">21742796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stylianopoulos T, Martin JD, Snuderl M, Mpekris F, Jain SR, Jain RK. Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. Cancer Res. 2013;73:3833–41. doi: 10.1158/0008-5472.CAN-12-4521.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-12-4521</ArticleId>
            <ArticleId IdType="pmc">PMC3702668</ArticleId>
            <ArticleId IdType="pubmed">23633490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hay N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer. 2016;16(10):635–49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5516800</ArticleId>
            <ArticleId IdType="pubmed">27634447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cairns RA, Mak TW. The current state of cancer metabolism. Nat Rev Cancer. 2016;16:613–4. doi: 10.1038/nrc.2016.100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc.2016.100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vincent EE, Sergushichev A, Griss T, Gingras M-C, Samborska B, Ntimbane T, Coelho PP, Blagih J, Raissi TC, Choinière L. Mitochondrial phosphoenolpyruvate carboxykinase regulates metabolic adaptation and enables glucose-independent tumor growth. Mol Cell. 2015;60:195–207. doi: 10.1016/j.molcel.2015.08.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2015.08.013</ArticleId>
            <ArticleId IdType="pubmed">26474064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panieri E, Santoro M. ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis. 2016;7:e2253. doi: 10.1038/cddis.2016.105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cddis.2016.105</ArticleId>
            <ArticleId IdType="pmc">PMC5143371</ArticleId>
            <ArticleId IdType="pubmed">27277675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marengo B, Nitti M, Furfaro AL, Colla R, De Ciucis C, Marinari UM, Pronzato MA, Traverso N, Domenicotti C. Redox homeostasis and cellular antioxidant systems: crucial players in cancer growth and therapy. Oxid Med Cell Longev. 2016;2016:6235641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4932173</ArticleId>
            <ArticleId IdType="pubmed">27418953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fruman DA, Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov. 2014;13:140–56. doi: 10.1038/nrd4204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd4204</ArticleId>
            <ArticleId IdType="pmc">PMC3994981</ArticleId>
            <ArticleId IdType="pubmed">24481312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Los M, Maddika S, Erb B, Schulze‐Osthoff K. Switching Akt: from survival signaling to deadly response. Bioessays. 2009;31:492–5. doi: 10.1002/bies.200900005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/bies.200900005</ArticleId>
            <ArticleId IdType="pmc">PMC2954189</ArticleId>
            <ArticleId IdType="pubmed">19319914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coloff JL, Mason EF, Altman BJ, Gerriets VA, Liu T, Nichols AN, Zhao Y, Wofford JA, Jacobs SR, Ilkayeva O. Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells. J Biol Chem. 2011;286:5921–33. doi: 10.1074/jbc.M110.179101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M110.179101</ArticleId>
            <ArticleId IdType="pmc">PMC3037705</ArticleId>
            <ArticleId IdType="pubmed">21159778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004;64:3892–9. doi: 10.1158/0008-5472.CAN-03-2904.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-03-2904</ArticleId>
            <ArticleId IdType="pubmed">15172999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nogueira V, Park Y, Chen C-C, Xu P-Z, Chen M-L, Tonic I, Unterman T, Hay N. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell. 2008;14:458–70. doi: 10.1016/j.ccr.2008.11.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2008.11.003</ArticleId>
            <ArticleId IdType="pmc">PMC3038665</ArticleId>
            <ArticleId IdType="pubmed">19061837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94:909–50. doi: 10.1152/physrev.00026.2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00026.2013</ArticleId>
            <ArticleId IdType="pmc">PMC4101632</ArticleId>
            <ArticleId IdType="pubmed">24987008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ray PD, Huang B-W, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24:981–90. doi: 10.1016/j.cellsig.2012.01.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2012.01.008</ArticleId>
            <ArticleId IdType="pmc">PMC3454471</ArticleId>
            <ArticleId IdType="pubmed">22286106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979;59:527–605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">37532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12:931–47. doi: 10.1038/nrd4002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd4002</ArticleId>
            <ArticleId IdType="pubmed">24287781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Locasale JW, Cantley LC. Metabolic flux and the regulation of mammalian cell growth. Cell Metab. 2011;14:443–51. doi: 10.1016/j.cmet.2011.07.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2011.07.014</ArticleId>
            <ArticleId IdType="pmc">PMC3196640</ArticleId>
            <ArticleId IdType="pubmed">21982705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaynar H, Meral M, Turhan H, Keles M, Celik G, Akcay F. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu–Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett. 2005;227:133–9. doi: 10.1016/j.canlet.2004.12.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2004.12.005</ArticleId>
            <ArticleId IdType="pubmed">16112416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Kenneth HY, Yeo CJ, Calhoun ES. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011;475:106–9. doi: 10.1038/nature10189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10189</ArticleId>
            <ArticleId IdType="pmc">PMC3404470</ArticleId>
            <ArticleId IdType="pubmed">21734707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Gao S, Puigserver P, Brugge JS. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature. 2009;461:109–13. doi: 10.1038/nature08268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature08268</ArticleId>
            <ArticleId IdType="pmc">PMC2931797</ArticleId>
            <ArticleId IdType="pubmed">19693011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miar A, Hevia D, Muñoz-Cimadevilla H, Astudillo A, Velasco J, Sainz RM, Mayo JC. Manganese superoxide dismutase (SOD2/MnSOD)/catalase and SOD2/GPx1 ratios as biomarkers for tumor progression and metastasis in prostate, colon, and lung cancer. Free Radic Biol Med. 2015;85:45–55. doi: 10.1016/j.freeradbiomed.2015.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.04.001</ArticleId>
            <ArticleId IdType="pubmed">25866291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Upadhyay M, Samal J, Kandpal M, Singh OV, Vivekanandan P. The Warburg effect: insights from the past decade. Pharmacol Ther. 2013;137:318–30. doi: 10.1016/j.pharmthera.2012.11.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pharmthera.2012.11.003</ArticleId>
            <ArticleId IdType="pubmed">23159371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41:211–8. doi: 10.1016/j.tibs.2015.12.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2015.12.001</ArticleId>
            <ArticleId IdType="pmc">PMC4783224</ArticleId>
            <ArticleId IdType="pubmed">26778478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012;21:297–308. doi: 10.1016/j.ccr.2012.02.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2012.02.014</ArticleId>
            <ArticleId IdType="pmc">PMC3311998</ArticleId>
            <ArticleId IdType="pubmed">22439925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends Biochem Sci. 2014;39:347–54. doi: 10.1016/j.tibs.2014.06.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2014.06.005</ArticleId>
            <ArticleId IdType="pmc">PMC4329227</ArticleId>
            <ArticleId IdType="pubmed">25037503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris IS, Treloar AE, Inoue S, Sasaki M, Gorrini C, Lee KC, Yung KY, Brenner D, Knobbe-Thomsen CB, Cox MA. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell. 2015;27:211–22. doi: 10.1016/j.ccell.2014.11.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccell.2014.11.019</ArticleId>
            <ArticleId IdType="pubmed">25620030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Desideri E, Filomeni G, Ciriolo MR. Glutathione participates in the modulation of starvation-induced autophagy in carcinoma cells. Autophagy. 2012;8:1769–81. doi: 10.4161/auto.22037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/auto.22037</ArticleId>
            <ArticleId IdType="pmc">PMC3541287</ArticleId>
            <ArticleId IdType="pubmed">22964495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Z, Odstrcil EA, Tu BP, McKnight SL. Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. Science. 2007;316:1916–9. doi: 10.1126/science.1140958.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1140958</ArticleId>
            <ArticleId IdType="pubmed">17600220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22:377–88. doi: 10.1038/cdd.2014.150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2014.150</ArticleId>
            <ArticleId IdType="pmc">PMC4326572</ArticleId>
            <ArticleId IdType="pubmed">25257172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23:27–47. doi: 10.1016/j.cmet.2015.12.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2015.12.006</ArticleId>
            <ArticleId IdType="pmc">PMC4715268</ArticleId>
            <ArticleId IdType="pubmed">26771115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang S, Yang C, Yang Z, Zhang D, Ma X, Mills G, Liu Z. Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect. Am J Cancer Res. 2015;5:928.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4449427</ArticleId>
            <ArticleId IdType="pubmed">26045978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmad IM, Aykin-Burns N, Sim JE, Walsh SA, Higashikubo R, Buettner GR, Venkataraman S, Mackey MA, Flanagan SW, Oberley LW. Mitochondrial and H2O2 mediate glucose deprivation-induced stress in human cancer cells. J Biol Chem. 2005;280:4254–63. doi: 10.1074/jbc.M411662200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M411662200</ArticleId>
            <ArticleId IdType="pubmed">15561720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birsoy K, Possemato R, Lorbeer FK, Bayraktar EC, Thiru P, Yucel B, Wang T, Chen WW, Clish CB, Sabatini DM. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature. 2014;508:108–12. doi: 10.1038/nature13110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature13110</ArticleId>
            <ArticleId IdType="pmc">PMC4012432</ArticleId>
            <ArticleId IdType="pubmed">24670634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moley K, Mueckler M. Glucose transport and apoptosis. Apoptosis. 2000;5:99–105. doi: 10.1023/A:1009697908332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1009697908332</ArticleId>
            <ArticleId IdType="pubmed">11232248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graham NA, Tahmasian M, Kohli B, Komisopoulou E, Zhu M, Vivanco I, Teitell MA, Wu H, Ribas A, Lo RS. Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death. Mol Syst Biol. 2012;8:589. doi: 10.1038/msb.2012.20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/msb.2012.20</ArticleId>
            <ArticleId IdType="pmc">PMC3397414</ArticleId>
            <ArticleId IdType="pubmed">22735335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee YJ, Galoforo SS, Berns CM, Chen JC, Davis BH, Sim JE, Corry PM, Spitz DR. Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells. J Biol Chem. 1998;273:5294–9. doi: 10.1074/jbc.273.9.5294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.273.9.5294</ArticleId>
            <ArticleId IdType="pubmed">9478987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blackburn R, Spitz D, Liu X, Galoforo S, Sim J, Ridnour L, Chen J, Davis B, Corry P, Lee Y. Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. Free Radic Biol Med. 1999;26:419–30. doi: 10.1016/S0891-5849(98)00217-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0891-5849(98)00217-2</ArticleId>
            <ArticleId IdType="pubmed">9895234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao M, Liang J, Lu Y, Guo H, German P, Bai S, Jonasch E, Yang X, Mills GB, Ding Z. Site-specific activation of AKT protects cells from death induced by glucose deprivation. Oncogene. 2014;33:745–55. doi: 10.1038/onc.2013.2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2013.2</ArticleId>
            <ArticleId IdType="pmc">PMC3874430</ArticleId>
            <ArticleId IdType="pubmed">23396361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zu XL, Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun. 2004;313:459–65. doi: 10.1016/j.bbrc.2003.11.136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2003.11.136</ArticleId>
            <ArticleId IdType="pubmed">14697210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinelle K, Doverskog M, Jacobsson U, Chapman BE, Kuchel PW, Häggström L. Elevated glutamate dehydrogenase flux in glucose‐deprived hybridoma and myeloma cells: Evidence from 1H/15N NMR. Biotechnol Bioeng. 1998;60:508–17. doi: 10.1002/(SICI)1097-0290(19981120)60:4&lt;508::AID-BIT13&gt;3.0.CO;2-D.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1097-0290(19981120)60:4&lt;508::AID-BIT13&gt;3.0.CO;2-D</ArticleId>
            <ArticleId IdType="pubmed">10099457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang C, Sudderth J, Dang T, Bachoo RG, McDonald JG, DeBerardinis RJ. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res. 2009;69:7986–93. doi: 10.1158/0008-5472.CAN-09-2266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-09-2266</ArticleId>
            <ArticleId IdType="pmc">PMC2764330</ArticleId>
            <ArticleId IdType="pubmed">19826036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sonveaux P, Végran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest. 2008;118:3930–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2582933</ArticleId>
            <ArticleId IdType="pubmed">19033663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semenza GL. Tumor metabolism: cancer cells give and take lactate. J Clin Invest. 2008;118:3835–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2582934</ArticleId>
            <ArticleId IdType="pubmed">19033652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeon S-M, Chandel NS, Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature. 2012;485:661–5. doi: 10.1038/nature11066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11066</ArticleId>
            <ArticleId IdType="pmc">PMC3607316</ArticleId>
            <ArticleId IdType="pubmed">22660331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Willson JK, Markowitz S, Zhou S. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science. 2009;325:1555–9. doi: 10.1126/science.1174229.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1174229</ArticleId>
            <ArticleId IdType="pmc">PMC2820374</ArticleId>
            <ArticleId IdType="pubmed">19661383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci. 2007;104:19345–50. doi: 10.1073/pnas.0709747104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0709747104</ArticleId>
            <ArticleId IdType="pmc">PMC2148292</ArticleId>
            <ArticleId IdType="pubmed">18032601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13:251–62. doi: 10.1038/nrm3311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3311</ArticleId>
            <ArticleId IdType="pmc">PMC5726489</ArticleId>
            <ArticleId IdType="pubmed">22436748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie DG. AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol. 2015;33:1–7. doi: 10.1016/j.ceb.2014.09.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ceb.2014.09.004</ArticleId>
            <ArticleId IdType="pubmed">25259783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin L, Huang H, Liao W, Ma H, Liu J, Wang L, Huang N, Liao Y. MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect. Oncogene. 2015;34:2700–10. doi: 10.1038/onc.2014.204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2014.204</ArticleId>
            <ArticleId IdType="pubmed">25043301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang T, He W, Cui F, Xia J, Zhou R, Wu Z, Zhao Y, Shi M. MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells. Oncotarget. 2016;7(14):18085–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4951273</ArticleId>
            <ArticleId IdType="pubmed">26919111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaube B, Malvi P, Singh SV, Mohammad N, Viollet B, Bhat MK. AMPK maintains energy homeostasis and survival in cancer cells via regulating p38/PGC-1α-mediated mitochondrial biogenesis. Cell Death Discov. 2015;1:15063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4979508</ArticleId>
            <ArticleId IdType="pubmed">27551487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007;129:1261–74. doi: 10.1016/j.cell.2007.06.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2007.06.009</ArticleId>
            <ArticleId IdType="pmc">PMC2756685</ArticleId>
            <ArticleId IdType="pubmed">17604717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robey RB, Hay N. Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol. 2009;19(1):25–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2814453</ArticleId>
            <ArticleId IdType="pubmed">19130886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samani AA, Yakar S, LeRoith D, Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev. 2007;28:20–47. doi: 10.1210/er.2006-0001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/er.2006-0001</ArticleId>
            <ArticleId IdType="pubmed">16931767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 2001;15:1406–18. doi: 10.1101/gad.889901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.889901</ArticleId>
            <ArticleId IdType="pmc">PMC312709</ArticleId>
            <ArticleId IdType="pubmed">11390360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albert V, Hall MN. mTOR signaling in cellular and organismal energetics. Curr Opin Cell Biol. 2015;33:55–66. doi: 10.1016/j.ceb.2014.12.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ceb.2014.12.001</ArticleId>
            <ArticleId IdType="pubmed">25554914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimobayashi M, Hall MN. Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol. 2014;15:155–62. doi: 10.1038/nrm3757.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3757</ArticleId>
            <ArticleId IdType="pubmed">24556838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schieke SM, Phillips D, McCoy JP, Aponte AM, Shen R-F, Balaban RS, Finkel T. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem. 2006;281:27643–52. doi: 10.1074/jbc.M603536200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M603536200</ArticleId>
            <ArticleId IdType="pubmed">16847060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choo AY, Kim SG, Vander Heiden MG, Mahoney SJ, Vu H, Yoon S-O, Cantley LC, Blenis J. Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol Cell. 2010;38:487–99. doi: 10.1016/j.molcel.2010.05.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2010.05.007</ArticleId>
            <ArticleId IdType="pmc">PMC2896794</ArticleId>
            <ArticleId IdType="pubmed">20513425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kelly CJ, Hussien K, Fokas E, Kannan P, Shipley RJ, Ashton TM, Stratford M, Pearson N, Muschel RJ. Regulation of O 2 consumption by the PI3K and mTOR pathways contributes to tumor hypoxia. Radiother Oncol. 2014;111:72–80. doi: 10.1016/j.radonc.2014.02.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.radonc.2014.02.007</ArticleId>
            <ArticleId IdType="pmc">PMC4070024</ArticleId>
            <ArticleId IdType="pubmed">24631147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eijkelenboom A, Burgering BM. FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol. 2013;14:83–97. doi: 10.1038/nrm3507.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3507</ArticleId>
            <ArticleId IdType="pubmed">23325358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiacchiera F, Simone C. The AMPK-FoxO3A axis as a target for cancer treatment. Cell Cycle. 2010;9:1091–6. doi: 10.4161/cc.9.6.11035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/cc.9.6.11035</ArticleId>
            <ArticleId IdType="pubmed">20190568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Méndez-Lucas A, Hyroššová P, Novellasdemunt L, Viñals F, Perales JC. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability. J Biol Chem. 2014;289:22090–102. doi: 10.1074/jbc.M114.566927.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M114.566927</ArticleId>
            <ArticleId IdType="pmc">PMC4139223</ArticleId>
            <ArticleId IdType="pubmed">24973213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Montal ED, Dewi R, Bhalla K, Ou L, Hwang BJ, Ropell AE, Gordon C, Liu W-J, DeBerardinis RJ, Sudderth J. PEPCK coordinates the regulation of central carbon metabolism to promote cancer cell growth. Mol Cell. 2015;60:571–83. doi: 10.1016/j.molcel.2015.09.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2015.09.025</ArticleId>
            <ArticleId IdType="pmc">PMC4656111</ArticleId>
            <ArticleId IdType="pubmed">26481663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallace M, Metallo CM. PGC1 [alpha] drives a metabolic block on prostate cancer progression. Nat Cell Biol. 2016;18:589–90. doi: 10.1038/ncb3365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb3365</ArticleId>
            <ArticleId IdType="pubmed">27230528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vazquez F, Lim J-H, Chim H, Bhalla K, Girnun G, Pierce K, Clish CB, Granter SR, Widlund HR, Spiegelman BM. PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell. 2013;23:287–301. doi: 10.1016/j.ccr.2012.11.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2012.11.020</ArticleId>
            <ArticleId IdType="pmc">PMC3708305</ArticleId>
            <ArticleId IdType="pubmed">23416000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiacchiera F, Simone C. Inhibition of p38α unveils an AMPK-FoxO3A axis linking autophagy to cancer-specific metabolism. Autophagy. 2009;5:1030–3. doi: 10.4161/auto.5.7.9252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/auto.5.7.9252</ArticleId>
            <ArticleId IdType="pubmed">19587525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang F, Marshall CB, Yamamoto K, Li G-Y, Gasmi-Seabrook GM, Okada H, Mak TW, Ikura M. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment. Proc Natl Acad Sci. 2012;109:6078–83. doi: 10.1073/pnas.1119073109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1119073109</ArticleId>
            <ArticleId IdType="pmc">PMC3341034</ArticleId>
            <ArticleId IdType="pubmed">22474372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K, Fukamizu A. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc Natl Acad Sci U S A. 2005;102:11278–83. doi: 10.1073/pnas.0502738102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0502738102</ArticleId>
            <ArticleId IdType="pmc">PMC1183558</ArticleId>
            <ArticleId IdType="pubmed">16076959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin H-JR, Kim H, Oh S, Lee J-G, Kee M, Ko H-J, Kweon M-N, Won K-J, Baek SH. AMPK–SKP2–CARM1 signalling cascade in transcriptional regulation of autophagy. Nature. 2016;534(7608):553–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5568428</ArticleId>
            <ArticleId IdType="pubmed">27309807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP, Brunet A. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem. 2007;282:30107–19. doi: 10.1074/jbc.M705325200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M705325200</ArticleId>
            <ArticleId IdType="pubmed">17711846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiacchiera F, Matrone A, Ferrari E, Ingravallo G, Lo Sasso G, Murzilli S, Petruzzelli M, Salvatore L, Moschetta A, Simone C. p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription. Cell Death Differ. 2009;16:1203–14. doi: 10.1038/cdd.2009.36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2009.36</ArticleId>
            <ArticleId IdType="pubmed">19343039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhong S, Salomoni P, Pandolfi PP. The transcriptional role of PML and the nuclear body. Nat Cell Biol. 2000;2:E85–90. doi: 10.1038/35010583.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35010583</ArticleId>
            <ArticleId IdType="pubmed">10806494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shackelford DB, Shaw RJ. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 2009;9:563–75. doi: 10.1038/nrc2676.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc2676</ArticleId>
            <ArticleId IdType="pmc">PMC2756045</ArticleId>
            <ArticleId IdType="pubmed">19629071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klotz L-O, Sánchez-Ramos C, Prieto-Arroyo I, Urbánek P, Steinbrenner H, Monsalve M. Redox regulation of FoxO transcription factors. Redox Biol. 2015;6:51–72. doi: 10.1016/j.redox.2015.06.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.redox.2015.06.019</ArticleId>
            <ArticleId IdType="pmc">PMC4511623</ArticleId>
            <ArticleId IdType="pubmed">26184557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burgering BM, Medema RH. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol. 2003;73:689–701. doi: 10.1189/jlb.1202629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.1202629</ArticleId>
            <ArticleId IdType="pubmed">12773501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang H, Tindall DJ. Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Biochim Biophys Acta (BBA)-Mol Cell Res. 2011;1813:1961–4. doi: 10.1016/j.bbamcr.2011.01.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamcr.2011.01.007</ArticleId>
            <ArticleId IdType="pmc">PMC3110514</ArticleId>
            <ArticleId IdType="pubmed">21238503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horman S, Vertommen D, Heath R, Neumann D, Mouton V, Woods A, Schlattner U, Wallimann T, Carling D, Hue L. Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase α-subunits in heart via hierarchical phosphorylation of Ser485/491. J Biol Chem. 2006;281:5335–40. doi: 10.1074/jbc.M506850200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M506850200</ArticleId>
            <ArticleId IdType="pubmed">16340011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soltys C-LM, Kovacic S, Dyck JR. Activation of cardiac AMP-activated protein kinase by LKB1 expression or chemical hypoxia is blunted by increased Akt activity. Am J Phys Heart Circ Phys. 2006;290:H2472–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16428351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valentine RJ, Coughlan KA, Ruderman NB, Saha AK. Insulin inhibits AMPK activity and phosphorylates AMPK Ser 485/491 through Akt in hepatocytes, myotubes and incubated rat skeletal muscle. Arch Biochem Biophys. 2014;562:62–9. doi: 10.1016/j.abb.2014.08.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.abb.2014.08.013</ArticleId>
            <ArticleId IdType="pmc">PMC4437572</ArticleId>
            <ArticleId IdType="pubmed">25172224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley SA, Ross FA, Gowans GJ, Tibarewal P, Leslie NR, Hardie DG. Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells. Biochem J. 2014;459:275–87. doi: 10.1042/BJ20131344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20131344</ArticleId>
            <ArticleId IdType="pmc">PMC4052680</ArticleId>
            <ArticleId IdType="pubmed">24467442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ning J, Xi G, Clemmons DR. Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells. Endocrinology. 2011;152:3143–54. doi: 10.1210/en.2011-0155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2011-0155</ArticleId>
            <ArticleId IdType="pmc">PMC3138225</ArticleId>
            <ArticleId IdType="pubmed">21673100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berggreen C, Gormand A, Omar B, Degerman E, Göransson O. Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. Am J Physiol Endocrinol Metab. 2009;296:E635–46. doi: 10.1152/ajpendo.90596.2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.90596.2008</ArticleId>
            <ArticleId IdType="pubmed">19158325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuznetsov JN, Leclerc GJ, Leclerc GM, Barredo JC. AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia. Mol Cancer Ther. 2011;10:437–47. doi: 10.1158/1535-7163.MCT-10-0777.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1535-7163.MCT-10-0777</ArticleId>
            <ArticleId IdType="pmc">PMC3053424</ArticleId>
            <ArticleId IdType="pubmed">21262957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King TD, Song L, Jope RS. AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3. Biochem Pharmacol. 2006;71:1637–47. doi: 10.1016/j.bcp.2006.03.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bcp.2006.03.005</ArticleId>
            <ArticleId IdType="pmc">PMC1618797</ArticleId>
            <ArticleId IdType="pubmed">16620785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tzatsos A, Tsichlis PN. Energy depletion inhibits phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794. J Biol Chem. 2007;282:18069–82. doi: 10.1074/jbc.M610101200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M610101200</ArticleId>
            <ArticleId IdType="pubmed">17459875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ning J, Clemmons DR. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. Mol Endocrinol. 2010;24:1218–29. doi: 10.1210/me.2009-0474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/me.2009-0474</ArticleId>
            <ArticleId IdType="pmc">PMC2875806</ArticleId>
            <ArticleId IdType="pubmed">20363874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zakikhani M, Blouin M-J, Piura E, Pollak MN. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Res Treat. 2010;123:271–9. doi: 10.1007/s10549-010-0763-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10549-010-0763-9</ArticleId>
            <ArticleId IdType="pubmed">20135346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bertrand L, Ginion A, Beauloye C, Hebert AD, Guigas B, Hue L, Vanoverschelde J-L. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am J Phys Heart Circ Phys. 2006;291:H239–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16489105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jakobsen SN, Hardie DG, Morrice N, Tornqvist HE. 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem. 2001;276:46912–6. doi: 10.1074/jbc.C100483200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.C100483200</ArticleId>
            <ArticleId IdType="pubmed">11598104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tao R, Gong J, Luo X, Zang M, Guo W, Wen R, Luo Z. AMPK exerts dual regulatory effects on the PI3K pathway. J Mol Signal. 2010;5:1. doi: 10.1186/1750-2187-5-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1750-2187-5-1</ArticleId>
            <ArticleId IdType="pmc">PMC2848036</ArticleId>
            <ArticleId IdType="pubmed">20167101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gual P, Le Marchand-Brustel Y, Tanti J-F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie. 2005;87:99–109. doi: 10.1016/j.biochi.2004.10.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biochi.2004.10.019</ArticleId>
            <ArticleId IdType="pubmed">15733744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leclerc GM, Leclerc GJ, Fu G, Barredo JC. AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia. J Mol Signal. 2010;5:15. doi: 10.1186/1750-2187-5-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1750-2187-5-15</ArticleId>
            <ArticleId IdType="pmc">PMC2955666</ArticleId>
            <ArticleId IdType="pubmed">20863384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Priebe A, Tan L, Wahl H, Kueck A, He G, Kwok R, Opipari A, Liu JR. Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells. Gynecol Oncol. 2011;122:389–95. doi: 10.1016/j.ygyno.2011.04.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ygyno.2011.04.024</ArticleId>
            <ArticleId IdType="pubmed">21570709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He N, Kim N, Jeong E, Lu Y, Mills GB, Yoon S. Glucose starvation induces mutation and lineage-dependent adaptive responses in a large collection of cancer cell lines. Int J Oncol. 2016;48:67–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4734611</ArticleId>
            <ArticleId IdType="pubmed">26573869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim Y-N, Koo KH, Sung JY, Yun U-J, Kim H. Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol. 2012;2012:306879.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3296207</ArticleId>
            <ArticleId IdType="pubmed">22505926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ng T, Leprivier G, Robertson M, Chow C, Martin M, Laderoute K, Davicioni E, Triche T, Sorensen P. The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis. Cell Death Differ. 2012;19:501–10. doi: 10.1038/cdd.2011.119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2011.119</ArticleId>
            <ArticleId IdType="pmc">PMC3278733</ArticleId>
            <ArticleId IdType="pubmed">21941369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fung C, Lock R, Gao S, Salas E, Debnath J. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol Biol Cell. 2008;19:797–806. doi: 10.1091/mbc.E07-10-1092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1091/mbc.E07-10-1092</ArticleId>
            <ArticleId IdType="pmc">PMC2262959</ArticleId>
            <ArticleId IdType="pubmed">18094039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muranen T, Selfors LM, Worster DT, Iwanicki MP, Song L, Morales FC, Gao S, Mills GB, Brugge JS. Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. Cancer Cell. 2012;21:227–39. doi: 10.1016/j.ccr.2011.12.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2011.12.024</ArticleId>
            <ArticleId IdType="pmc">PMC3297962</ArticleId>
            <ArticleId IdType="pubmed">22340595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avivar-Valderas A, Bobrovnikova-Marjon E, Diehl JA, Bardeesy N, Debnath J, Aguirre-Ghiso JA. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Oncogene. 2013;32:4932–40. doi: 10.1038/onc.2012.512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2012.512</ArticleId>
            <ArticleId IdType="pmc">PMC3600386</ArticleId>
            <ArticleId IdType="pubmed">23160380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peiris-Pagès M, Martinez-Outschoorn UE, Pestell RG, Sotgia F, Lisanti MP. Cancer stem cell metabolism. Breast Cancer Res. 2016;18:1. doi: 10.1186/s13058-016-0712-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13058-016-0712-6</ArticleId>
            <ArticleId IdType="pmc">PMC4879746</ArticleId>
            <ArticleId IdType="pubmed">27220421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458:780–3. doi: 10.1038/nature07733.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature07733</ArticleId>
            <ArticleId IdType="pmc">PMC2778612</ArticleId>
            <ArticleId IdType="pubmed">19194462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Francesco AM, Toesca A, Cenciarelli C, Giordano A, Gasbarrini A, Puglisi MA. Metabolic modification in gastrointestinal cancer stem cells: characteristics and therapeutic approaches. J Cell Physiol. 2016;231(10):2081–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26791139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanduja S, Feng Y, Mathis R, Sokol E, Reinhardt F, Halaban R, Gupta P. AMPK promotes tolerance to Ras pathway inhibition by activating autophagy. Oncogene. 2016;35(40):5295–303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6086350</ArticleId>
            <ArticleId IdType="pubmed">27041569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao C, Zhang Q, Yu T, Sun S, Wang W, Liu G. Hypoxia promotes drug resistance in osteosarcoma cells via activating AMP-activated protein kinase (AMPK) signaling. J Bone Oncol. 2016;5:22–9. doi: 10.1016/j.jbo.2016.01.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jbo.2016.01.002</ArticleId>
            <ArticleId IdType="pmc">PMC4782021</ArticleId>
            <ArticleId IdType="pubmed">26998423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harhaji‐Trajkovic L, Vilimanovich U, Kravic‐Stevovic T, Bumbasirevic V, Trajkovic V. AMPK‐mediated autophagy inhibits apoptosis in cisplatin‐treated tumour cells. J Cell Mol Med. 2009;13:3644–54. doi: 10.1111/j.1582-4934.2009.00663.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1582-4934.2009.00663.x</ArticleId>
            <ArticleId IdType="pmc">PMC4516513</ArticleId>
            <ArticleId IdType="pubmed">20196784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8:579–91. doi: 10.1038/nrd2803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd2803</ArticleId>
            <ArticleId IdType="pubmed">19478820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhong D, Liu X, Schafer-Hales K, Marcus AI, Khuri FR, Sun S-Y, Zhou W. 2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition. Mol Cancer Ther. 2008;7:809–17. doi: 10.1158/1535-7163.MCT-07-0559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1535-7163.MCT-07-0559</ArticleId>
            <ArticleId IdType="pubmed">18413794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pusapati RV, Daemen A, Wilson C, Sandoval W, Gao M, Haley B, Baudy AR, Hatzivassiliou G, Evangelista M, Settleman J. mTORC1-dependent metabolic reprogramming underlies escape from glycolysis addiction in cancer cells. Cancer Cell. 2016;29:548–62. doi: 10.1016/j.ccell.2016.02.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccell.2016.02.018</ArticleId>
            <ArticleId IdType="pubmed">27052953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheong H, Lu C, Lindsten T, Thompson CB. Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol. 2012;30:671–8. doi: 10.1038/nbt.2285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nbt.2285</ArticleId>
            <ArticleId IdType="pmc">PMC3876738</ArticleId>
            <ArticleId IdType="pubmed">22781696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhardwaj R, Sharma PK, Jadon S, Varshney R. A combination of 2-deoxy-D-glucose and 6-aminonicotinamide induces cell cycle arrest and apoptosis selectively in irradiated human malignant cells. Tumor Biol. 2012;33:1021–30. doi: 10.1007/s13277-012-0335-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13277-012-0335-1</ArticleId>
            <ArticleId IdType="pubmed">22328137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simons AL, Ahmad IM, Mattson DM, Dornfeld KJ, Spitz DR. 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Res. 2007;67:3364–70. doi: 10.1158/0008-5472.CAN-06-3717.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-06-3717</ArticleId>
            <ArticleId IdType="pmc">PMC3852417</ArticleId>
            <ArticleId IdType="pubmed">17409446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhaskar PT, Hay N. The two TORCs and AKT. Dev Cell. 2007;12:487–502. doi: 10.1016/j.devcel.2007.03.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2007.03.020</ArticleId>
            <ArticleId IdType="pubmed">17419990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lo M, Ling V, Low C, Wang Y, Gout P. Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer. Curr Oncol. 2010;17:9–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2880911</ArticleId>
            <ArticleId IdType="pubmed">20567622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, Raman V, Bhujwalla ZM, Felsher DW, Cheng L, Pevsner J. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell. 2007;12:230–8. doi: 10.1016/j.ccr.2007.08.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2007.08.004</ArticleId>
            <ArticleId IdType="pmc">PMC2084208</ArticleId>
            <ArticleId IdType="pubmed">17785204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cramer SL, Saha A, Liu J, Tadi S, Tiziani S, Yan W, Triplett K, Lamb C, Alters SE, Rowlinson S. Systemic depletion of L-cyst (e) ine with cyst (e) inase increases reactive oxygen species and suppresses tumor growth. Nat Med. 2017;23(1):120–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5218918</ArticleId>
            <ArticleId IdType="pubmed">27869804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandel NS, Tuveson DA. The promise and perils of antioxidants for cancer patients. N Engl J Med. 2014;371:177–8. doi: 10.1056/NEJMcibr1405701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMcibr1405701</ArticleId>
            <ArticleId IdType="pubmed">25006725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C, Dalin MG, Akyürek LM, Lindahl P, Nilsson J. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med. 2015;7:308re308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26446958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ, Morrison SJ. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015;527(7577):186–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4644103</ArticleId>
            <ArticleId IdType="pubmed">26466563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6:221ra215. doi: 10.1126/scitranslmed.3007653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.3007653</ArticleId>
            <ArticleId IdType="pubmed">24477002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Liu X, Long M, Huang Y, Zhang L, Zhang R, Zheng Y, Liao X, Wang Y, Liao Q. NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis. Sci Transl Med. 2016;8:334ra351.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27075625</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
